Reporting owner · CIK 0001258693

Pickering Grant

Visual SEC Form 4 history across 1 companies, 12 transactions and 3 filings.

CEOCHIEF EXECUTIVE OFFICERVaxcyte, Inc.
Open-market mix
Latest filingSep 02, 2026, 11:57 PM
Filings3Form 4 records
Buying$00 purchases
Selling$167.1K6 sales
Net value−$167.1KBuys minus sells
Companies12 securities
Most recentSep 02, 2026withholding

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
1050-5-106Jan 24Feb 25Mar 25Aug 26Sep 26

Net value flow

Buys minus sells

Jan 24
−$167.1K
Feb 25
$0
Mar 25
$0
Aug 26
$0
Sep 26
$0

Transaction texture

Ownership and ticket size

Average P/S size$27.9K
Median P/S size$37K
Direct6
Indirect6
Sep 02, 2026withholding

Filing-only signals

Deterministic matches in this insider's history

Cluster Sellingpattern6Derivative Transactionfiling-context1Direct Ownershipfiling-context4Large Holdings Increaseholdings1Repeat Sellerpattern210b5-1 Detectedfiling-context6

Latest Form 4 facts

Quick context from source filings

Latest transaction

sale at Vaxcyte, Inc. on Jan 02, 2024 valued at $41,304.

Review SEC filing
Latest buy

No open-market insider purchase is available.

Associated companies

Visual map of known reporting history

PCVXVaxcyte, Inc.12 transactions · latest Sep 02, 2026, 11:57 PM
TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
PCVXPICKERING GRANT
CEO
withholding3.42k-$21.1MF
Direct Ownership
0.0%09/0209/02
PCVXPICKERING GRANT
CEO
withholding2.86k-$17.3MF
Direct Ownership
0.0%09/0208/31
PCVXPICKERING GRANT
CEO
grant193k$0A
Derivative Transaction Direct Ownership Large Holdings Increase
—03/04/202502/27/2025
PCVXPICKERING GRANT
CEO
withholding7.98k-$57.5MF
Direct Ownership
—03/04/202503/03/2025
PCVXPICKERING GRANT
CEO
withholding2.01k-$14.6MF
Direct Ownership
—03/04/202502/28/2025
PCVXPICKERING GRANT
CEO
grant57.9k$0A
Direct Ownership
—03/04/202503/27/2025
PCVXPICKERING GRANT
CEO
sale10b5-1643-$4.13MS
Cluster Selling Repeat Seller 10b5-1 Detected
—01/04/202401/02/2024
PCVXPICKERING GRANT
CEO
sale10b5-1568-$3.61MS
Cluster Selling Repeat Seller 10b5-1 Detected
—01/04/202401/02/2024
PCVXPICKERING GRANT
CEO
sale10b5-197-$610kS
Cluster Selling 10b5-1 Detected
—01/04/202401/02/2024
PCVXPICKERING GRANT
CEO
sale10b5-1587-$3.77MS
Cluster Selling 10b5-1 Detected
—01/04/202401/02/2024

Pickering Grant Insider Activity FAQ

SEC Form 4 context

Who is Pickering Grant?

Pickering Grant is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001258693.

Which companies has Pickering Grant reported transactions for?

Vaxcyte, Inc.

When was Pickering Grant's latest insider buy?

No open-market insider purchase is available for this period.

When was Pickering Grant's latest insider sale?

sale at Vaxcyte, Inc. on Jan 02, 2024 valued at $41,304.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.